Newland Pharmaceutical Co., Ltd. (SHE:301277)
China
· Delayed Price · Currency is CNY 12.31
-0.08 (-0.65%)
Mar 9, 2026, 4:00 PM EDT
Newland Pharmaceutical Revenue
Newland Pharmaceutical had revenue of 122.43M CNY in the quarter ending September 30, 2025, a decrease of -12.85%. This brings the company's revenue in the last twelve months to 670.43M, down -4.03% year-over-year. In the year 2024, Newland Pharmaceutical had annual revenue of 726.44M with 11.51% growth.
Revenue (ttm)
670.43M
Revenue Growth
-4.03%
P/S Ratio
7.29
Revenue / Employee
643.41K
Employees
1,042
Market Cap
4.89B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jianmin Pharmaceutical Group | 3.18B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Zhejiang Yatai Pharmaceutical | 326.64M |
| Tibet Weixinkang Medicine | 1.17B |
| Shanghai Jiaoda Onlly Co.,Ltd | 312.75M |
| Jinling Pharmaceutical Company | 3.13B |
| Yabao Pharmaceutical Group | 2.27B |